FDA approves first-in-class drug to treat narcolepsy
FDA approves first-in-class drug to treat narcolepsy Drug Discovery News
Regulatory Approvals
FDA Approves RP1 Plus Nivolumab for Advanced Melanoma
FDA Approves RP1 Plus Nivolumab for Advanced Melanoma Dermatology Times
FDA approves Orzeyful for narcolepsy type 1 in adults
FDA approves Orzeyful for narcolepsy type 1 in adults American Academy of Sleep Medicine | AASM
FDA Approves First mRNA Flu Vaccine – respiratory
FDA Approves First mRNA Flu Vaccine respiratory-therapy.com
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease Novartis